Mannitol & MANNITOL 2080 Excipient Use in For Solution Dosage Forms

Mannitol

FDA Inactive Ingredient Details, DESCRIPTION

Suppliers

39 Listed Products, 1 Ingredion Pharma Solutions, 1 Pfanstiehl, 11 Roquette, 12 SPI Pharma, 1 Shijiazhuang Huaxu Pharmaceutical, 2 Microlex e.U, 1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Pluviaendo, 2 Gangwal Healthcare, 2 Gangwal Chemicals, 1 BASF, 2 Kerry, 1 Rochem International Inc, 1 Sigachi Industries

REGULATORY FILINGS

17 Suppliers, 16 USDMF, 3 CEP/COS, 3 NDC API

SOLUTIONS BY APPLICATIONS

25 Fillers, Diluents & Binders, 10 Direct Compression, 10 Chewable & Orodispersible Aids, 9 Taste Masking, 5 Parenteral, 4 Co-Processed Excipients, 3 Granulation, 3 Disintegrants & Superdisintegrants, 1 API Stability Enhancers, 1 Thickeners and Stabilizers

REF. STANDARDS & IMPURITIES

1 Others

1 Others

FINISHED FORMULATIONS

499 ORAL, 278 TABLET, 130 INJECTABLE, 85 INJECTION, 68 TABLET, ORALLY DISINTEGRATING, 65 INTRAVENOUS, 42 CAPSULE, 33 OPHTHALMIC, 33 POWDER, 28 SOLUTION/DROPS, 28 TABLET, EXTENDED RELEASE, 26 TABLET, CHEWABLE, 23 TABLET, DELAYED RELEASE, 22 SUBLINGUAL, 16 FOR SUSPENSION, 12 SUBCUTANEOUS, 11 CAPSULE, DELAYED REL PELLETS, 10 SOLUTION, 8 BUCCAL, 8 GUM, CHEWING, 8 INTRAVENOUS, SUBCUTANEOUS, 7 FOR SOLUTION, 7 TABLET, FOR SUSPENSION, 6 GRANULE, 5 CAPSULE, EXTENDED RELEASE, 5 INTRAMUSCULAR, 5 TROCHE/LOZENGE, 3 VIAL, 2 BUCCAL, SUBLINGUAL, 2 ORAL-21, 2 ORAL-28, 2 SUSPENSION/DROPS, 2 TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE, 1 CAPSULE, DELAYED RELEASE, 1 FOR SUSPENSION, DELAYED RELEASE, 1 FOR SUSPENSION, EXTENDED RELEASE, 1 GEL, 1 INJECTABLE, LIPOSOMAL, 1 INJECTABLE, TABLET, 1 INTRAMUSCULAR, ORAL, 1 INTRAVITREAL, 1 IV (INFUSION), 1 NASAL, 1 SINGLE-USE, 1 SOLUTION, GEL FORMING/DROPS, 1 SPRAY, METERED, 1 SUSPENSION, 1 SUSPENSION, EXTENDED RELEASE, 1 TABLET, EXTENDED RELEASE, CHEWABLE, 1 TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE